Global Estrone Market Size, Share and Trends Analysis Report, By Product Type (Cream, Tablet, and Injection), By Drug Type (Estragyn, Kestrin, Theelin, and Other), Forecast Period (2022-2028)

The global estrone market is anticipated to grow at a CAGR of 6.2% during the forecast period (2022-2028). Estrone was marketed as oestrogen in intramuscular and vaginal formulations for the treatment of low oestrogen symptoms such as hot flashes and vaginal atrophy in postmenopausal or ovariectomized women. Estrone has also been used to treat prostate cancer in males as an antigonadotropin and a kind of high-dose oestrogen, as well as to treat breast cancer in women. For instance, Starting at age 50, 5 years of Menopausal Hormone Therapy would increase breast cancer incidence by about one in every 50 users of oestrogen plus daily progestagen preparations, one in every 70 users of oestrogen plus intermittent progestagen preparations, and one in every 200 users of oestrogen-only preparations between the ages of 50 and 69. The excesses associated with ten years of Menopausal Hormone Therapy would be roughly twice as high.

Birth and abortion rates are likely to be affected by the social structure, religious beliefs, economic prosperity, and urbanization of each country. Developed countries have a lower fertility rate due to lifestyle choices. As a result, the need for and demand for medications that increase estrone levels is increasing. Estrone and estropipate are used to treat gonadotropin hormone malfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy caused by menopause, as well as to prevent osteoporosis caused by oestrogen shortage.

Some major players in the market are Bayer AG, Flavine, Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Symbiotec Pharmalab Pvt. Ltd., Zhejiang Xianju Junye Pharmaceutical Co., Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Company’s Product Portfolio

Estragyn Vaginal Cream is used to treat the symptoms of menopause and postmenopause. For women with intact uteri, Estragyn Vaginal Cream should be administered with a suitable dose of progestin to avoid endometrial hyperplasia/carcinoma. Estragyn Vaginal Cream is only meant to be used for a brief period of time.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Product Type
  • By Drug Type
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape– Bayer AG, Flavine, Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Symbiotec Pharmalab Pvt. Ltd., Zhejiang Xianju Junye Pharmaceutical Co., Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Estrone Market Report by Segment

By Product Type

• Cream
• Tablet
• Injection

By Drug Type

• Estragyn
• Kestrin
• Theelin

Global Estrone Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa